- Home
- WAL vs BMRN Comparison
WAL vs BMRN Comparison
Compare WAL & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAL | BMRN |
|---|---|---|
| Founded | 1994 | 1996 |
| Country | United States | United States |
| Employees | 3524 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.4B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | WAL | BMRN |
|---|---|---|
| Price | $80.53 | $56.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 18 |
| Target Price | ★ $91.69 | $88.22 |
| AVG Volume (30 Days) | 1.0M | ★ 2.2M |
| Earning Date | 04-21-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $1,313,646,000.00 |
| Revenue This Year | $20.49 | $15.02 |
| Revenue Next Year | $8.08 | $12.23 |
| P/E Ratio | ★ $10.88 | $104.61 |
| Revenue Growth | N/A | ★ 17.62 |
| 52 Week Low | $65.82 | $49.26 |
| 52 Week High | $97.23 | $66.28 |
Technical Indicators
Market Signals| Indicator | WAL | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 58.18 |
| Support Level | $74.06 | $51.74 |
| Resistance Level | $81.21 | $56.91 |
| Average True Range (ATR) | 2.00 | 1.89 |
| MACD | 0.20 | 0.53 |
| Stochastic Oscillator | 85.48 | 88.17 |
Price Performance
Historical ComparisonAbout WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.